CGNT vs NICE vs VRNS

For growth investors, Varonis Systems, Inc.

(VRNS) is the stronger pick with 13. 2% revenue growth year-over-year, versus 7. 7% for NICE Ltd. (NICE). NICE Ltd. (NICE) offers the better valuation at 10. 0x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, NICE Ltd.

is actually cheaper at 8. 8x.

Over the past 5 years, Varonis Systems, Inc.

(VRNS) delivered a total return of -41. 4%, compared to -58. 2% for NICE Ltd. (NICE). Over 10 years, the gap is even starker: VRNS returned +303. 7% versus CGNT's -62. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), NICE Ltd.

(NICE) is the lower-risk stock at 0. 72β versus Cognyte Software Ltd. 's 1. 27β — meaning CGNT is approximately 76% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 96% for Varonis Systems, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Varonis Systems, Inc.

(VRNS) is pulling ahead at 13. 2% versus 7. 7% for NICE Ltd. (NICE). On earnings-per-share growth, the picture is similar: NICE Ltd. grew EPS 43. 0% year-over-year, compared to -31. 4% for Varonis Systems, Inc.. Over a 3-year CAGR, NICE leads at 10. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

NICE Ltd.

(NICE) is the more profitable company, earning 20. 8% net margin versus -20. 7% for Varonis Systems, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -23. 5% for VRNS. At the gross margin level — before operating expenses — VRNS leads at 79. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, NICE Ltd.

(NICE) trades at 8. 8x forward P/E versus 233. 2x for Varonis Systems, Inc. — 224. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 55. 8% to $150. 88.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, NICE Ltd.

(NICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Both have compounded well over 10 years (NICE: +51. 7%, CGNT: -62. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CGNT is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; VRNS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.